Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Pagis V, Astouati Q, Pacoureau L, Nguyen Y, Bay P, Roux A, Gallay L, Cottin V, Terrier B, Meyer A, Cerf C, Neuville M, Hervier B, Renaud A, Suzon B, Schleinitz N, Papo T, Priou P, Mekinian A, Ullmer A, Oehler E, Gensous N, Berezne A, Martin LS, Marhadour T, Martin M, Servettaz A, Samson M, Gilardin L, Charles P, Woessner J, Carmoi T, Dilly B, Mauhin W, Baillet N, Humbert S, Thoreau B, Lemaitre M, Pendu CL, Loiseau P, Quemeneur T, Blanchard E, Voermans N, Launay D, Nunes H, Benveniste O, Uzunhan Y, Allenbach Y.
Pagis V, et al. Among authors: cottin v.
J Intern Med. 2025 Nov 24. doi: 10.1111/joim.70047. Online ahead of print.
J Intern Med. 2025.
PMID: 41277275